Research Article
Identification of SOX6 and SOX12 as Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma: A Retrospective Study Based on TCGA Database
Table 3
The association between SOX6 expression and clinicopathologic factors.
| | Clinical features | Type | Total | High | Low | value |
| | Age | >60 | 266 (50.19%) | 128 (48.3%) | 138 (52.08%) | 0.4343 | | ≤60 | 264 (49.81%) | 137 (51.7%) | 127 (47.92%) | |
| | Gender | Female | 186 (35.09%) | 106 (40%) | 80 (30.19%) | | | Male | 344 (64.91%) | 159 (60%) | 185 (69.81%) | |
| | Stage | Stage I | 265 (50.28%) | 151 (57.41%) | 114 (43.18%) | | | Stage II | 57 (10.82%) | 31 (11.79%) | 26 (9.85%) | | | Stage III | 123 (23.34%) | 52 (19.77%) | 71 (26.89%) | | | Stage IV | 82 (15.56%) | 29 (11.03%) | 53 (20.08%) | |
| | Grade | G1 | 14 (2.68%) | 8 (3.07%) | 6 (2.3%) | | | G2 | 227 (43.49%) | 132 (50.57%) | 95 (36.4%) | | | G3 | 206 (39.46%) | 102 (39.08%) | 104 (39.85%) | | | G4 | 75 (14.37%) | 19 (7.28%) | 56 (21.46%) | |
| | T | T1 | 271 (51.13%) | 156 (58.87%) | 115 (43.4%) | | | T2 | 69 (13.02%) | 33 (12.45%) | 36 (13.58%) | | | T3 | 179 (33.77%) | 74 (27.92%) | 105 (39.62%) | | | T4 | 11 (2.08%) | 2 (0.75%) | 9 (3.4%) | |
| | N | N0 | 239 (93.73%) | 123 (96.85%) | 116 (90.62%) | 0.0732 | | N1 | 16 (6.27%) | 4 (3.15%) | 12 (9.38%) | |
| | M | M0 | 420 (84.34%) | 221 (88.76%) | 199 (79.92%) | | | M1 | 78 (15.66%) | 28 (11.24%) | 50 (20.08%) | |
|
|
|
